| Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336) |
|---|
| 09/24/2002 | US6455523 Inhibitors of farnesyl protein transferase |
| 09/24/2002 | US6455521 Psychological disorders; side effect reduction |
| 09/19/2002 | WO2002072585A2 Substituted pyrazolopyrimidines and thiazolopyrimidines used as analgesics |
| 09/19/2002 | WO2002072109A1 Substituted 3',4'-di-o-camphanoyl-(+)-cis-khellactone analogs, compositions thereof, and methods for using thereof |
| 09/19/2002 | WO2002072089A2 Use of thiolutin dioxide and its derivatives in the manufacture of a medicament for the treatment of cns disorders and a process for the preparation thereof |
| 09/19/2002 | WO2002071827A2 Retinoid x receptor modulators |
| 09/19/2002 | WO2002042311A3 Biotin derivatives, methods for making same and uses thereof as vectors |
| 09/19/2002 | US20020133018 Calcium channel blockers; cardiovascular disorders; side effect reduction |
| 09/19/2002 | US20020132826 Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 09/19/2002 | US20020132818 Thienopyrimidines |
| 09/19/2002 | US20020132812 Oral hypoglycaemic agents |
| 09/19/2002 | CA2439853A1 Use of thiolutin dioxide and its derivatives in the manufacture of a medicament for the treatment of cns disorders and a process for the preparation thereof |
| 09/19/2002 | CA2438586A1 Retinoid x receptor modulators |
| 09/18/2002 | EP1240144A2 Compound having effect of promoting neuron differentiation |
| 09/18/2002 | EP0944386B1 Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds |
| 09/18/2002 | EP0837847B1 2,4,5-trisubstituted phenylketo-enols for use as pesticides and herbicides |
| 09/18/2002 | EP0764158B1 Benzopyrans and their use as therapeutic agents |
| 09/18/2002 | CN1370176A Subsstituted heterocycle fused gamma-carbolines |
| 09/18/2002 | CN1370175A Dithiepino [6,5-b] pyridines, and related compsns. and methods |
| 09/18/2002 | CN1370173A Isomeric fused pyrrolocarbazoles and isoindolones |
| 09/18/2002 | CN1370169A Substituted heterocycle fused gamma-carbolines |
| 09/17/2002 | US6451843 Arylphenyl-substituted cyclic keto enols |
| 09/17/2002 | US6451842 Cyclic amine derivatives and their use as drugs |
| 09/17/2002 | US6451796 Fused pyrazine compounds |
| 09/17/2002 | US6451792 Matrix metalloprotease inhibitors |
| 09/17/2002 | CA2218654C Synthesis of (s)-3-(2-thienylthio) butyric acid and analogs |
| 09/12/2002 | WO2002070511A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| 09/12/2002 | WO2001077684A3 Proteomic analysis using activity-based probe libraries |
| 09/12/2002 | US20020128308 Useful as medicines having an osteogenesis promoting effect and chondrogensis promoting effect. |
| 09/12/2002 | US20020128263 Treatment or prevention of mGluR5 receptor mediated disorders. |
| 09/12/2002 | CA2437594A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| 09/11/2002 | EP1238668A1 Use of thiolutin dioxide and its derivatives in the manufacture of a medicament for the treatment of CNS disorders and a process for the preparation thereof |
| 09/11/2002 | EP1237849A1 Activators of soluble guanylate cyclase |
| 09/11/2002 | EP0934309B1 New pyridyl alkane acid amides as cytostatics and immunosuppressives |
| 09/11/2002 | CN1368970A Substituted 1,4-dihydroindeno [1,2-C] pyrazoles as inhibitors of tyrosine kinase |
| 09/11/2002 | CN1368960A Indole derivatives, process for their preparation, pharmaceutical compositions containing them and their medicinal application |
| 09/11/2002 | CN1368848A Heterocyclic spiro compounds as pesticides |
| 09/10/2002 | US6448283 Fused pyrrolocarbazoles; hearing loss and loss of the sense of balance |
| 09/10/2002 | US6448247 Tachykinin receptor antagonist; especially to the receptors for substance p (which receptors are generally referred to as ?neurokinin 1 receptors?) |
| 09/06/2002 | WO2002068415A1 Pyrazole compounds useful as protein kinase inhibitors |
| 09/06/2002 | WO2002068399A1 Aryl carbamate derivatives, preparation and use thereof |
| 09/06/2002 | WO2002050029A3 Tetracyclic derivatives as spla2 inhibitors |
| 09/06/2002 | WO2002038563A3 Condensed pyrazindione derivatives as pde inhibitors |
| 09/06/2002 | WO2002007714A3 Use of anellated dihydropyridines for the preparation of pharmaceutical compositions for the treatment of chronic pain |
| 09/06/2002 | CA2438828A1 Aryl carbamate derivatives, preparation and use thereof |
| 09/05/2002 | US20020123506 7-Heterocyclyl quinoline and thieno(2,3-b)pyridine derivatives useful as antagonists of gonadotropin releasing hormone |
| 09/05/2002 | US20020123502 5-(4-(2-(2,4-dimethyl-6-oxo-1,6-dihydro-1-pyrimidinyl) -ethoxy)phenyl methyl)thiazolidine-2,4-dione for example; also oxazolidine-2,4-dione, and 1,2,4-oxadiazolidine-3,5-dione derivatives; reducing blood glucose levels |
| 09/05/2002 | US20020123488 Pyrazine and triazine derivatives of 1,2,4,5-tetrahydro-Benzo or Thieno [d] azepine |
| 09/05/2002 | US20020123032 Detection of disease related genes |
| 09/04/2002 | EP1235803A1 Urea compounds having muscarinic receptor antagonist activity |
| 09/04/2002 | EP1235802A1 Carbamate derivatives having muscarinic receptor antagonist activity |
| 09/04/2002 | EP1235577A2 Protease inhibitors |
| 09/04/2002 | EP1036076B1 Novel compounds |
| 09/04/2002 | CN1090190C Heterocycle-condensed morphinoid derivatives and its preparing method and use |
| 09/04/2002 | CN1090189C Pyrazolopyrimidines type compound |
| 09/03/2002 | US6444823 Pyridyl alkane acid amides as cytostatics and immunosuppressives |
| 09/03/2002 | US6444672 Heterocyclic derivatives and their use as antithrombotic agents |
| 08/29/2002 | WO2002066483A1 Copolymer composition having pigment like properties |
| 08/29/2002 | WO2002066469A2 Novel heterocyclic amide derivatives and their use as dopamine d3 receptor ligands |
| 08/29/2002 | WO2002066468A2 Heterocyclic urea derivatives and their use as dopamine d3 receptor ligands |
| 08/29/2002 | WO2002066461A1 Pyrazole compounds useful as protein kinase inhibitors |
| 08/29/2002 | WO2002066446A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands |
| 08/29/2002 | WO2002066075A2 Biotin-derivatives and their conjugates with chelating agents |
| 08/29/2002 | WO2002028858A3 Hexahydropyrazino `1'2' : 1, 6!- pyrido `3, 4-b! indole-1, 4-dione derivatives for the treatment of cardiovascular disorders and erectile disfunction |
| 08/29/2002 | WO2002018383A3 Aza heterocyclic derivatives and their therapeutic use |
| 08/29/2002 | WO2001087845A3 N-containing heterocyclic compounds and their use as 5-ht antagonists |
| 08/29/2002 | WO2001012584A3 Pharmaceutical compounds |
| 08/29/2002 | WO1999064055A9 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors |
| 08/29/2002 | US20020120152 Aminoaryl oxazolidinone N-oxides |
| 08/29/2002 | US20020119973 Antiinflammatory agents |
| 08/29/2002 | US20020119305 Controlled release composition |
| 08/29/2002 | CA2438318A1 Novel heterocyclic amide derivatives and their use as dopamine d3 receptor ligands |
| 08/29/2002 | CA2438316A1 Heterocyclic urea derivatives and their use as dopamine d3 receptor ligands |
| 08/29/2002 | CA2438264A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands |
| 08/28/2002 | EP0892804B1 Isoxazolidine derivatives |
| 08/28/2002 | EP0856001B1 Pyrimidine derivatives as 5ht2c receptor antagonists |
| 08/27/2002 | US6441188 Aminoaryl oxazolidinone N-oxides |
| 08/27/2002 | US6441172 Diketodiazacyclic compounds, diazacyclic compounds and combinatorial libraries thereof |
| 08/27/2002 | US6441169 Pyrimidin-2-oxy-4-one and pyrimidin-2-oxy-4-thione derivatives |
| 08/27/2002 | US6441030 3-phenyl-pyrones |
| 08/27/2002 | US6441019 Cyclocarbamate and cyclic amide derivatives |
| 08/27/2002 | US6440963 Use of selective COX-2 inhibitors for the treatment of urinary incontinence |
| 08/27/2002 | US6440618 Imaging element containing a blocked photographically useful compound |
| 08/22/2002 | WO2002064598A1 Thieno'2,3-d pyrimidindione derivatives as matrix metalloproteinase inhibitors |
| 08/22/2002 | WO2002064588A1 2-heteroaryl-3,4-dihydro-2h-pyrrole derivatives and the use thereof as pesticides |
| 08/22/2002 | WO2002064584A1 Phthalayinone-piperidino-derivatives as pde4 inhibitors |
| 08/22/2002 | WO2002064565A1 Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical |
| 08/22/2002 | WO2002064546A2 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical |
| 08/22/2002 | WO2002064545A1 Acylated indanyl amines and their use as pharmaceuticals |
| 08/22/2002 | WO2002064080A2 Matrix metalloproteinase inhibitors |
| 08/22/2002 | WO2002048112A3 7-heterocyclyl quinoline and thieno[2,3-b]pyridine derivatives useful as antagonists of gonadotropin releasing hormone |
| 08/22/2002 | WO2002040471A3 Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents) |
| 08/22/2002 | US20020115856 Selective cyclooxygenase-2 (COX-2) inhibitors; for example, 1-(5-Methanesulfonyl-pyridin-2-yl)-7-methoxy-3-trifluoromethyl-4,5-dihydro -1H-benzo(g)indazole |
| 08/22/2002 | US20020115854 Thrombin or factor Xa inhibitors |
| 08/22/2002 | US20020115706 Treatment of both hearing loss and loss of the sense of balance by administering a a fused pyrrolocarbazole derivative |
| 08/22/2002 | US20020115671 Inhibitors of p38-a kinase |
| 08/22/2002 | US20020115566 Halogenated calixpyrroles, calixpyridinopyrroles and calixpyridines, and uses thereof |
| 08/22/2002 | CA2437643A1 Matrix metalloproteinase inhibitors |
| 08/22/2002 | CA2433778A1 Thieno'2,3-d pyrimidindione derivatives as matrix metalloproteinase inhibitors |
| 08/21/2002 | EP1231922A1 Protease inhibitors |